131 related articles for article (PubMed ID: 2661768)
1. Cyclosporine and azathioprine immunosuppression without maintenance steroids: a prospective randomized trial.
Esmore DS; Spratt PM; Keogh AM; Chang VP
J Heart Transplant; 1989; 8(3):194-9. PubMed ID: 2661768
[TBL] [Abstract][Full Text] [Related]
2. Impacts of low-dose steroids and prophylactic monoclonal versus polyclonal antibodies on acute rejection in cyclosporine- and azathioprine-immunosuppressed cardiac allografts.
Laufer G; Laczkovics A; Wollenek G; Schreiner W; Sochor H; Holzinger C; Buchelt M; Fasol R; Wolner E
J Heart Transplant; 1989; 8(3):253-61. PubMed ID: 2661776
[TBL] [Abstract][Full Text] [Related]
3. Heart transplantation in females.
Esmore D; Keogh A; Spratt P; Jones B; Chang V
J Heart Lung Transplant; 1991; 10(3):335-41. PubMed ID: 1854761
[TBL] [Abstract][Full Text] [Related]
4. Five-year follow-up of a randomized double-drug versus triple-drug therapy immunosuppressive trial after heart transplantation.
Keogh A; Macdonald P; Mundy J; Chang V; Harvison A; Spratt P
J Heart Lung Transplant; 1992; 11(3 Pt 1):550-5; discussion 556. PubMed ID: 1610863
[TBL] [Abstract][Full Text] [Related]
5. Are steroids essential for successful maintenance of immunosuppression in heart transplantation?
Katz MR; Barnhart GR; Szentpetery S; Rider S; Thompson JA; Hess M; Hastillo A; Lower RR
J Heart Transplant; 1987; 6(5):293-7. PubMed ID: 3316555
[TBL] [Abstract][Full Text] [Related]
6. Rabbit antithymocyte globulin. A 10-year experience in cardiac transplantation.
Copeland JG; Icenogle TB; Williams RJ; Rosado LJ; Butman SM; Vasu MA; Sethi GK; McDonald AN; Klees E; Rhenman MJ
J Thorac Cardiovasc Surg; 1990 May; 99(5):852-60. PubMed ID: 2329823
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppression after heart transplantation: prednisone and cyclosporine with and without azathioprine.
Casale AS; Reitz BA; Greene PS; Augustine S; Baumgartner WA
J Thorac Cardiovasc Surg; 1989 Nov; 98(5 Pt 2):951-5. PubMed ID: 2811426
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of minimal dosage cyclosporine in limiting toxicity and rejection.
Spratt P; Esmore D; Baron D; Shanahan MX; Farnsworth AE; Chang VP
J Heart Transplant; 1986; 5(1):8-12. PubMed ID: 3302158
[TBL] [Abstract][Full Text] [Related]
9. A prospective comparison of murine monoclonal CD-3 (OKT3) antibody-based and equine antithymocyte globulin-based rejection prophylaxis in cardiac transplantation. Decreased rejection and less corticosteroid use with OKT3.
Renlund DG; O'Connell JB; Gilbert EM; Hammond ME; Burton NA; Jones KW; Karwande SV; Doty DB; Menlove RL; Herrick CM
Transplantation; 1989 Apr; 47(4):599-605. PubMed ID: 2523099
[TBL] [Abstract][Full Text] [Related]
10. [Results, over a 3-year, period of a triple combination: cyclosporin, azathioprine, prednisolone in high-risk kidney transplants].
Hiesse C; Rieu P; Neyrat N; Charpentier B; Benoit G; Bellamy J; Fries D
Nephrologie; 1987; 8(3):127-9. PubMed ID: 3309700
[TBL] [Abstract][Full Text] [Related]
11. Comparison of three immunosuppressive regimens in cadaver renal transplantation: long-term cyclosporine, short-term cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisolone without cyclosporine.
Hall BM; Tiller DJ; Hardie I; Mahony J; Mathew T; Thatcher G; Miach P; Thomson N; Sheil AG
N Engl J Med; 1988 Jun; 318(23):1499-507. PubMed ID: 3285215
[TBL] [Abstract][Full Text] [Related]
12. Initial steroid-free versus steroid-based maintenance therapy and steroid withdrawal after heart transplantation: two views of the steroid question.
Keogh A; Macdonald P; Harvison A; Richens D; Mundy J; Spratt P
J Heart Lung Transplant; 1992; 11(2 Pt 2):421-7. PubMed ID: 1571340
[TBL] [Abstract][Full Text] [Related]
13. Antithymocyte gamma globulin, low-dosage cyclosporine, and tapering steroids as an immunosuppressive regimen to avoid early kidney failure in heart transplantation.
Deeb GM; Kolff J; McClurken JB; Dunn J; Balsara R; Ochs R; Badellino M; Hollander T; Eldridge C; Clancey M
J Heart Transplant; 1987; 6(2):79-83. PubMed ID: 3305833
[TBL] [Abstract][Full Text] [Related]
14. A prospective randomized controlled trial of initial immunosuppression with ALG versus OKT3 in recipients of cardiac allografts.
Menkis AH; Powell AM; Novick RJ; McKenzie FN; Kostuk WJ; Pflugfelder PW; Brown JE; Rochon J; Chow LH; Stiller C
J Heart Lung Transplant; 1992; 11(3 Pt 1):569-76. PubMed ID: 1610866
[TBL] [Abstract][Full Text] [Related]
15. Management of rejection in heart transplant recipients: does moderate rejection always require treatment?
Hutter JA; Wallwork J; English TA
J Heart Transplant; 1990; 9(2):87-91. PubMed ID: 2319377
[TBL] [Abstract][Full Text] [Related]
16. Increased rejection in gender-mismatched grafts: amelioration by triple therapy.
Keogh AM; Valantine HA; Hunt SA; Schroeder JS; Oyer PE
J Heart Lung Transplant; 1991; 10(1 Pt 1):106-10. PubMed ID: 2007161
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of accelerated coronary artery disease in heart transplant survivors. Comparison of cyclosporine and azathioprine regimens.
Gao SZ; Schroeder JS; Alderman EL; Hunt SA; Valantine HA; Wiederhold V; Stinson EB
Circulation; 1989 Nov; 80(5 Pt 2):III100-5. PubMed ID: 2805287
[TBL] [Abstract][Full Text] [Related]
18. Conversion from cyclosporine to azathioprine improves renal function without increased risk of graft failure.
Maddux MS; Veremis SA; Pollak R; Mozes MF
Transplant Proc; 1987 Feb; 19(1 Pt 3):2007-9. PubMed ID: 3079066
[TBL] [Abstract][Full Text] [Related]
19. Reduced incidence of severe infection after heart transplantation with low-intensity immunosuppression.
Reid KR; Menkis AH; Novick RJ; Pflugfelder PW; Kostuk WJ; Reid J; Whitby JL; Powell AM; McKenzie FN
J Heart Lung Transplant; 1991; 10(6):894-900. PubMed ID: 1756154
[TBL] [Abstract][Full Text] [Related]
20. Heart allograft rejection under varying immunosuppressive protocols as evaluated by endomyocardial biopsy.
Imakita M; Tazelaar HD; Billingham ME
J Heart Transplant; 1986; 5(4):279-85. PubMed ID: 3305819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
